• Articles

    ONS Answers Your Top Questions About Cancer Immunotherapy
  • Articles

    FDA Approves Neratinib for Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
  • Articles

    The Case of the Immunotherapy Inquiry, Part II
  • Articles

    Walls and a Blue Ribbon
  • Articles

    Who Is Monitoring Your Infusions for Administration Safety?
  • Articles

    Management of Immunotherapy-Related Endocrinopathies
  • Articles

    Symptom Distress in Patients With Hepatocellular Carcinoma Toward the End of Life
  • Articles

    A Qualitative Study Exploring Models of Supportive Care in Men and Their Partners/Caregivers Affected by Metastatic Prostate Cancer
  • Articles

    Adherence and Coping Strategies in Outpatients With Chronic Myeloid Leukemia Receiving Oral Tyrosine Kinase Inhibitors
  • Articles

    Energy Through Motion: An Activity Intervention for Cancer-Related Fatigue in an Ambulatory Infusion Center